milgamma^® protekt : For the treatment of nerve damages due to vitamin B1 deficiency

milgamma^® protect – your solution for nerve damage caused by diabetes-related vitamin B1 deficiency

People with diabetes often may become aware of their nerve damage through altered sensations like tingling, burning, numbness and pain in the feet. This nerve damage (neuropathies) is often caused by a vitamin B1 deficiency. What starts with slight sensations like tingling or burning, can lead to significant pain and numbness. When heat, cold, pressure and pain are no longer felt, problems can be expected. If foot injuries are not perceived, they often remain unrecognized and untreated. Various consequences could follow leading up to the ‘diabetic foot syndrome’.

milgamma^® protekt can contribute to successfully counteracting these nerve disorders. It contains the active substance benfotiamine, a precursor of vitamin B1, that effectively compensates for the vitamin B1 deficiency which is common among diabetic patients. milgamma^® protekt compensates the nerve damaging vitamin B1 deficiency and relieves the symptoms of tingling, burning and numbness in the feet with only one tablet per day.

• What is vitamin B1 and why is it so important for our body? 
• Why can a vitamin B1 deficiency damage the nerves?
• Tingling in the legs? This helps!

Vitamin B1 deficiency in diabetics
Diabetics have an increased risk of vitamin B1 deficiency: they excrete more of the important "nerve vitamin" via the kidneys. This can easily lead to a vitamin B1 deficiency², which can cause or exacerbate neuropathies. What starts with mild symptoms such as a tingling or burning sensation can lead to severe pain and numbness in the legs. If the sensation of heat, cold, pressure and pain is also lost, serious problems can be expected: Injuries to the foot are no longer perceived and are therefore often not recognized and treated.

• Read more about vitamin B1 deficiency in diabetics here.
• Tips for diabetics with vitamin B1 deficiency can be found here.

¹ Schreeb KH, Freudenthaler S, Vormfelder SV et al. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate. Eur J Clin Pharmacol 1997; 52 (4): 319–320.
² Thornalley PJ, Babaei-Jadidi R, Al Ali H et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007 Oct; 50 (10): 2164–2170.